Calpain Activation and Organ Failure in Sepsis: Molecular Insights and Therapeutic Perspectives.

Yifan Huang, Grace Wang, Tianqing Peng

Journal: Shock (Augusta, Ga.) 2022;56(1):5-15

PMID: 33038189

Abstract

Sepsis is a severe systemic response to infection; its ensuing organ failure commonly portends an unfavorable prognosis. Despite the fact that sepsis has been studied for decades, the molecular mechanisms underlying sepsis-induced organ dysfunction remain elusive and more complex than previously thought, and effective therapies are extremely limited. Calpain is a type of calcium-dependent cysteine protease that includes dozens of isoforms. Calpain, as well as its endogenous-specific inhibitor calpastatin, have been implicated in the pathogenesis of sepsis-induced organ dysfunction. Further, there is an accumulating body of evidence supporting the beneficial effect of calpain inhibition or regulation on multiple organ failure in sepsis. Better understanding of the underlying molecular mechanisms is helpful in the development of calpain/calpastatin-targeted therapeutic strategies to protect against sepsis-induced organ injury. The aim of this review is to summarize the recent literature and evidence surrounding the role of the calpain/calpastatin system in the process of organ dysfunction caused by sepsis-including regulation of cell death, modulation of inflammatory response, and disruption of critical proteins-to provide guidance for future research and therapy development.

Copyright © 2020 by the Shock Society.

Address: Institutes of Biology and Medical Sciences, Soochow University, Suzhou, China.; Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; Critical Illness Research, Lawson Health Research Institute of London Health Sciences Centre, London, Ontario, Canada.; Departments of Medicine and Pathology and Laboratory Medicine, Western University, London, Ontario, Canada.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.